CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.77 -0.13 (-14.19%)
As of: Oct 2, 2026 · 12:13 PM EDT

CytoMed Therapeutics (GDTC) Amortization - Intangibles (2025 - 2026)

Updated

CytoMed Therapeutics (GDTC) recorded Amortization - Intangibles of -$29,900 in FY2025, compared with -$12,557 in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Amortization - Intangibles (2025 - 2026) Analysis & Trends

Starting with FY2020, CytoMed Therapeutics' Amortization - Intangibles history includes 6 years.

  • The FY2025 figure is the lowest annual Amortization - Intangibles in data going back to FY2020.
  • Per Business Quant data, GDTC's Amortization - Intangibles was -$12,557 in FY2024, -$2,187 in FY2023, -$2,500 in FY2022 and -$2,512 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,849.00
Jun 30, 2025 321.00
API Access

CytoMed Therapeutics Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=GDTC&period=max&api_key=YOUR_API_KEY